Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.
Delta Sleep-Inducing Peptide, a nonapeptide marketed for sleep, withdrawal and recovery. Not a clean first candidate for any established use.
Sleep is a strong male-health need, driving interest despite weak data.
| Claim | Strongest evidence |
|---|---|
| Sleep / insomnia | R Regulatory only |
| Recovery / withdrawal | D Cell / mechanistic |
FDA noted gaps in safety/effectiveness and the availability of approved therapies for the evaluated conditions; staff proposed not adding it.
Weak human data. Approved sleep therapies already exist and are better characterized.
No. FDA noted safety/effectiveness gaps and proposed not adding it.
One email when regulatory status changes or strong new evidence lands. Health topics only. Unsubscribe anytime.
Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.